Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_2

14%

Ph early_phase_1

29%

Ph not_applicable

57%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Early Phase 1First-in-human

2(28.6%)

Phase 2Efficacy & side effects

1(14.3%)

N/ANon-phased studies

4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Detailed Status

Completed5

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 2

Trials by Phase

Early Phase 12 (28.6%)

Phase 21 (14.3%)

N/A4 (57.1%)

Trials by Status

terminated114%

withdrawn114%

completed571%

Recent Activity

0 active trials

Showing 5 of 7

terminatednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT05057793Not Applicable

Efficacy Study for Geko Device in VLU Patients (Canada)

Terminated

NCT04391257Not Applicable

Study of gekoTM Interaction With Cardiac Pacemakers

Completed

NCT02482038Not Applicable

Geko Venous Leg Ulcer Study

Completed

NCT02425917Not Applicable

IPC-CALF Versus GEKO in Post-op Total Hip Patients

Withdrawn

NCT01835990Phase 2

Feasibility Study of Geko vs. IPCs in Trauma

Completed

NCT01981733Early Phase 1

Improving Lower Limb Blood Flow in Healthy Adult Volunteers

Completed

NCT01979328Early Phase 1

Geko™ Plaster Cast Study, Deep Vein Thrombosis (DVT) Prophylaxis

Completed

All 7 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 7